Cystatin C: current position and future prospects

S Seronie-Vivien, P Delanaye, L Pieroni… - Clinical chemistry and …, 2008 - degruyter.com
Cystatin C is a low-molecular-weight protein which has been proposed as a marker of renal
function that could replace creatinine. Indeed, the concentration of cystatin C is mainly …

Cystatin C: an emerging biomarker in cardiovascular disease

C Angelidis, S Deftereos… - Current topics in …, 2013 - ingentaconnect.com
Cystatin C (cys-C) is a small protein molecule (120 amino acid peptide chain, approximately
13kDa) produced by virtually all nucleated cells in the human body. It belongs to the family …

[HTML][HTML] How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?

JV Salgado, FL Souza, BJ Salgado - Journal of cardiology, 2013 - Elsevier
The association of cystatin C with renal function has been studied for more than 25 years.
Cystatin C has been described to have a better diagnostic performance than creatinine to …

Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox

G Niccoli, S Giubilato, L Di Vito, A Leo… - European heart …, 2013 - academic.oup.com
Aims We aimed to compare coronary artery disease (CAD) at the time of a first acute
coronary syndrome (ACS) in type II diabetic and non-diabetic patients by coronary …

Epicardial adipose tissue: a novel potential imaging marker of comorbidities caused by chronic inflammation

MG Tarsitano, C Pandozzi, G Muscogiuri, S Sironi… - Nutrients, 2022 - mdpi.com
The observation of correlations between obesity and chronic metabolic and cardiovascular
diseases has led to the emergence of strong interests in “adipocyte biology”, in particular in …

Cystatin C is correlated with mortality in patients with and without acute kidney injury

M Bell, F Granath, J Mårtensson… - Nephrology Dialysis …, 2009 - academic.oup.com
Background. Recent research has shown cystatin C to predict mortality and cardiovascular
morbidity independent of renal function. The aim of this study was to evaluate the prognostic …

Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis

A Ganda, M Magnusson, L Yvan-Charvet, B Hedblad… - Circulation, 2013 - Am Heart Assoc
Background—The number of circulating blood monocytes impacts atherosclerotic lesion
size, and in mouse models, elevated levels of high-density lipoprotein cholesterol suppress …

Relationship of cystatin C with coronary artery disease and its severity

YC Doganer, U Aydogan, A Aydogdu… - Coronary artery …, 2013 - journals.lww.com
Objective Cystatin C, which is an endogenous marker for renal function, is reported to be a
novel marker for coronary atherosclerosis. In this study, we aimed to evaluate its role in …

Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease

A Kiyosue, Y Hirata, J Ando, H Fujita, T Morita… - Circulation …, 2010 - jstage.jst.go.jp
Background: This study examines whether the serum concentration of cystatin C (Cys C)
correlates with the severity of coronary artery disease (CAD) and whether it provides …

Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome

C Ge, F Ren, S Lu, F Ji, X Chen… - Clinical Cardiology: An …, 2009 - Wiley Online Library
Background This article aims to investigate the changes of plasma cystatin C concentration
(PcyC), and to evaluate the relationship between PcyC and acute coronary syndrome …